Skip to main content
. 2022 Mar 15;14(3):607–627. doi: 10.4251/wjgo.v14.i3.607

Figure 5.

Figure 5

Immunohistochemistry in cholangiocarcinoma. A: Positive CK7 immunostaining; B: Positive CK19 immunostaining; C: Positive epithelial membrane antigen immunostaining; D: Hepatocyte nuclear factor-1 β nuclear immunostaining in a small duct variant of intrahepatic cholangiocarcinoma.